Pennsylvania is a reduced practice state, with NPs required to maintain a collaborative agreement with a physician
The insurer reviews the request to confirm the drug is medically necessary, meets their formulary criteria, and is appropriate for the patients diagnosis before theyll agree to cover it
PubMed, 2024 Glucagon-like peptide-1 receptor agonists and muscle strength changes in older adults British Journal of Pharmacology, 2025 Consuming more protein may protect patients taking an anti-obesity drug from muscle loss Endocrine Society, ENDO 2025 Preserving Lean Body Mass in Patients Taking GLP-1 for Weight Loss Mass General Advances in Motion GLP-1s and Lean Mass: What the Research Shows ACE Certified, June 2025 New GLP-1 Therapies Enhance Quality of Weight Loss by Improving Muscle Preservation American Diabetes Association, 2025 Impact of GLP-1 Receptor Agonist Therapy in Patients at High Risk for Sarcopenia Current Nutrition Reports, Springer, 2025
The company launched a similar campaign with NBA Hall of Famer Charles Barkley in April.
For blood sugar control, they work by increasing the release of insulin and reducing glucagon after you eat
Giacchetti G, Sechi LA, Rilli S, Carey RM (2005) The renin-angiotensin-aldosterone system, glucose metabolism and diabetes
